Daily Stock List
Environmental Tectonics Corp. (ETCC)
FeedBlitz, M2 Communications, and OTC Picks reported previously on Environmental Tectonics Corp. (ETCC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Environmental Tectonics Corp. designs, manufactures, and sells simulated environment systems for training, testing, and research and development. The Company mainly engages in the design, manufacture and sale of software driven products and services used to recreate and monitor the physiological effects of motion on humans and equipment and to control, modify, simulate and measure environmental conditions. Founded in 1969, Environmental Tectonics has their corporate headquarters in Southampton, Pennsylvania.
The Company's worldwide reach includes operational installations in more than 90 countries, with offices in the United States, Europe, Asia, Poland, Turkey and Egypt. Environmental Tectonics' Aircrew Training Systems provide the most advanced simulation trainers to the aerospace community, supporting training and research efforts in the areas of spatial disorientation, situational awareness, aircraft egress, night vision, upset recovery, high altitude and high G flight. The Company also offers their Tactical Flight Training Systems.
Environmental Tectonics ETC Sterilization Systems are for the life sciences, pharmaceutical and medical device industry. For automotive and HVAC test equipment they offer their ETC Testing and Simulation Systems. In addition, the Company's Hyperbaric BaraMed Monoplace Chambers meet the needs of clinical, diving, and research facilities. Furthermore, their Advanced Disaster Management Simulator, or ADMS, is an interactive, virtual-reality training platform for the emergency management, disaster preparedness, and homeland security and defense markets.
ETC-PZL is Environmental Tectonics' subsidiary in Warsaw, Poland. This subsidiary offers an innovative product line of flight and vehicle simulators to the global market. They do this while providing their engineering and visual simulation expertise throughout all of Environmental Tectonics' products. Moreover, ETC-TURKEY is the expert group behind the Company's cutting-edge software design. Additionally, Environmental Tectonics' National Aerospace Training and Research Center (the NASTAR Center) provides a complete aerospace training and research facility for those in the commercial, military and space flight industries.
Today, Environmental Tectonics' announced that their ETC BioMedical Systems Group delivered and installed three BARA-MED® Select™ hyperbaric chambers to St. Vincent Charity Medical Center; medical professionals praised the computerized systems as "state-of-the-art."
Environmental Tectonics Corp. (ETCC), closed Wednesday's trading session at $2.10, up 4.48%, on 7,300 volume with 6 trades. The average volume for the last 60 days is 3,127 and the stock's 52-week low/high is $1.01/$2.05.
Rathdowney Resources Ltd. (RTH.V)
Today we are reporting on Rathdowney Resources Ltd. (RTH.V), here at the QualityStocks Daily Newsletter.
Based in Vancouver, British Columbia, Rathdowney Resources Ltd. is a mineral exploration and development company. They focus on finding and developing the next generation of zinc deposits. Rathdowney Resources is associated with Hunter Dickinson, Inc. (HDI), a diversified, international mining group with more than 25 years of mineral development success. Rathdowney Resources' shares trade on the TSX Venture Exchange.
The Company's team consists of highly experienced management who are supported by high-caliber global advisers and leading industry consultants. Rathdowney has interests in Poland, Alaska and Ireland. The Company is advancing Project Olza (the contiguous Zawiercie, Rokitno and Chechlo concessions), a 150 square kilometer property situated in the premier Upper Silesian Mining District of Poland that hosts world-class Mississippi Valley-Type deposits. Because of the district's rich mining history, extensive infrastructure is readily available to new projects. This includes power and smelter facilities. Rathdowney Resources' ground is linked by rail to these facilities.
The Company has made a significant investment in Alaska by acquiring an 18 percent interest in Heatherdale Resources Ltd. Heatherdale owns the high-grade polymetallic volcanic massive sulphide (VMS) Niblack Project in southeast Alaska.
In Ireland, Rathdowney acquired eight properties and conducted early stage exploration. This included geophysical and geochemical surveys. They followed up by initial drill testing of priority targets. This work attracted the attention of major mining companies Teck Resources and Antofagasta that have taken options to earn up to 100 percent interests on all of Rathdowney Resources' Irish properties. Rathdowney retains Net Smelter Return (NSR) royalties on any future production.
In November 2012, Rathdowney Resources announced the results for 24 holes from their continuing drilling program in Poland. The new holes further demonstrate the strength and persistence of the zinc-lead mineralization at Project Olza. The current results are for holes OLZ-147, OLZ-159 and OLZ-179 to OLZ-200, located at drill centers in the northern, central and southern parts of the mineralized corridor at Project Olza. Rathdowney's drilling intersected high grades at Project Olza. This includes 27.3 m of 7.2 percent Zn+Pb in hole 147, 5.3 m of 9.2 percent Zn+Pb in hole 189, and 2.2 m of 36.1 percent Zn+Pb in hole 194.
Rathdowney Resources Ltd. (RTH.V), closed Wednesday's trading session at $0.46, up 2.22%, on 22,496 volume. The stock's 52-week low/high is $0.31/$0.58.
Oando Energy Resources, Inc. (OER.TO)
Today we are reporting on Oando Energy Resources, Inc. (OER.TO), here at the QualityStocks Daily Newsletter.
Listed on the Toronto Stock Exchange, Oando Energy Resources, Inc. currently has an extensive portfolio of producing, development and exploration assets in the Gulf of Guinea (predominantly in Nigeria). These have current production of approximately 4,125 barrels of oil per day. The Company has been specifically structured to take advantage of current opportunities for indigenous companies in Nigeria. This nation has one of the largest oil and gas resources in Africa. Oando Energy Resources has offices in Lagos, Nigeria, as well as Calgary, Alberta, and London, England.
Oando Energy Resources (OER) is the new trading name of Exile Resources, Inc. (Exile), post the acquisition of certain shareholding interests in Oando PLC's upstream subsidiary in respect of Oil Mining Leases (OMLs) and Oil Prospecting Licenses (OPLs). The Company's core and implementation strategy includes identifying and securing farm-in and acquisition opportunities.
Oando's focus is to target proven undeveloped fields with 2P reserves between 10mmboe–20mmboe and regular concessions with 2P reserves between 40mmboe–50mmboe. Additionally, they look to complete opportunistic acquisitions during asset sales and buy expired IOC concessions, as well as have their focus on Nigeria and evaluate other opportunities in the Gulf of Guinea.
Oando's strategic focus is on the acquisition of near term assets. The Company has a portfolio of oil and gas assets in Nigeria, EEZ (Exclusive Economic Zone), Zambia and Turkey. Oando holds interests in several licenses for exploration, development and production of oil and gas concessions. Their portfolio of assets is at varying stages of upstream operations: exploration, development and production.
In late December 2012, Oando Energy Resources announced an update regarding the damaged 10-inch Kwale-Akri oil delivery pipeline operated by Nigerian Agip Oil Co. Ltd. (NAOC) and connects Oando's Ebendo Field (OML 56) to the Brass export terminal.
The Kwale-Akri pipeline was fully repaired; it started operations with reduced volumes being injected into the pipeline for testing, to ensure full integrity before full volume capacity is attained. Gross production from the Ebendo Field (OML 56) recommenced at approximately 2,000 Barrels Per Day (bbls/day), (900 bbls/day net to Oando) with a gradual ramp-up to full gross production of 4,000 bbls/day expected as full pipeline integrity is confirmed.
Oando Energy Resources, Inc. (OER.TO), closed Wednesday's trading session at $1.14, up 2.70%, on 10,370 volume. The stock's 52-week low/high is $0.75/$1.89.
SGX Resources, Inc. (SXR.V)
We are highlighting SGX Resources, Inc. (SXR.V) today, here at the QualityStocks Daily Newsletter.
SGX Resources, Inc. is a gold exploration and development company that lists on the TSX Venture Exchange. The Company has properties in the Timmins region of Ontario. SGX Resources was originally created by the management of San Gold Corporation (TSX:SGR) to separate the operations and valuation of San Gold's Timmins properties from San Gold's core operations at their Rice Lake Mining Complex near Bissett, Manitoba. San Gold continues to hold a considerable stake in SGX Resources. Operating since December 2009, SGX Resources has their headquarters in Winnipeg, Manitoba.
The Company's operations are currently focusing on diamond drilling exploration for gold mineralization. At present, they are undertaking exploration programs on two properties - Timmins South in Sothman Township and Timmins North in Tully Township. SGX Resources also holds a 31.5 percent stake in the highly prospective Davidson-Tisdale property in Timmins. The Company also holds a position in other strategic lands to the west and south of Timmins, near current and past production.
SGX Resources discovered and they continue to build on the new near-surface Edleston gold deposit located approximately 60 km by road to the south of Timmins, Ontario, between the Young-Davidson mine to the east and the Cote Lake deposit to the west. They are also conducting additional exploration and infill drilling at the high-grade, near-surface Tully gold deposit, located approximately 25 km to the north of Timmins.
In late January 2013, Dale Ginn, President and Chief Executive Officer of SGX Resources reported that drilling has followed up on the new high-grade gold discovery located immediately to the south of the Edleston deposit. Drill hole #12-90 encountered three distinct high-grade intersections, cutting 2.7 meters of 7.1 g/tonne and 1.5 meters of 10.5 g/tonne and 1.3 meters of 8.7 g/tonne. Drill hole #12-90 is located immediately below and to the east of discovery hole #12-86, which produced a 6.3 meter interval of 68.5 g/tonne. Additional assay results are also being reported for Edleston Zone drilling that has successfully extended the main body eastward by more than 100 meters since November 2012.
Yesterday, SGX Resources reported that they signed an exploration agreement with Mattagami First Nation. The Agreement recognizes the rights, obligations, and responsibilities held by each party in relation to ongoing exploration activities on claims held by SGX Resources, which are in Mattagami traditional territory. Additionally, the Agreement identifies potential opportunities that may arise from exploration activities in these areas and provides methods for the Mattagami community to participate in these opportunities. The Agreement covers all present and future mineral dispositions and claims held by the Company; the Agreement is effective immediately.
SGX Resources, Inc. (SXR.V), closed Wednesday's trading session at $0.135, even for the day, on 7,300 volume. The stock's 52-week low/high is $1.01/$2.05.
Apollo Medical Holdings, Inc. (AMEH)
SmallCapVoice reported earlier on Apollo Medical Holdings, Inc. (AMEH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTCQB, Apollo Medical Holdings, Inc. (ApolloMed) is a leading provider of hospital-based services in Los Angeles, California and Central California. They offer a spectrum of services including, Hospitalist, Pulmonary Critical Care, Care Management and Consulting Services. The Company, through their affiliated medical groups, provides their services to more than 50 Health plans, Independent Physician Associations, and Hospitals. ApolloMed has their headquarters in Glendale, California.
Warren Hosseinion, M.D. and Adrian Vazquez, M.D. established the Company in June of 2001. Currently, ApolloMed has a presence at 29 hospitals in Los Angeles and the Central California Area. The organization of Hospitalist medicine is around the admission and care of patients in an inpatient facility such as a hospital or skilled nursing facility. It focuses on providing, managing and coordinating the care of hospitalized patients. ApolloMed employs affiliated hospitalists at 21 hospitals.
On July 10, 2012, ApolloMed ACO (Accountable Care Organization) received notification that they were selected by the Centers for Medicare and Medicaid Services (CMS) to participate in the Medicare Shared Savings Program (MSSP). The design of the Medicare Shared Savings Program model is to encourage the development of Accountable Care Organizations (ACOs), which can consist of hospitals, doctors and other health care providers who work together and are accountable for quality outcomes and the overall patient experience, while reducing the growth in Medicare expenditures. ApolloMed ACO was one of only eight ACOs selected to participate in the Medicare Shared Savings Program by CMS in California in 2012.
For the three months ended October 31, 2012, compared to the three months ended October 31, 2011, ApolloMed Net Revenues of $1,965,153 increased $533,188 or 37.2 percent over Net Revenues of $1,431,965. Specifically, $230,517 of the increase is due to the Company's acquisition of VMM and consolidation of Verdugo, and $302,671 of the increase is due to growth of fees for service revenues attributable to new hospital contracts, and expansion of services with existing medical group clients at new hospitals. Net Revenues consist of net billings under the different fee structures from health plans, medical groups/IPA's and hospitals, and income from service fee agreements.
Apollo Medical Holdings, Inc. (AMEH), closed Wednesday's trading session at $0.63, up 10.53%, on 1,000 volume with 1 trade. The average volume for the last 60 days is 5,389 and the stock's 52-week low/high is $0.08/$1.38.
Andain, Inc. (ANDN)
Today we are highlighting Andain, Inc. (ANDN), here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Andain, Inc. involves in the biotech and medical fields. The Company specializes in identifying technical innovations and providing a unique incubator/accelerator development and industrial platform. Founded in 2004, they also offer technical knowledge and business strategy expertise to commercialize new technologies into products. Their team of experts manages all technological, medical, regulatory and other aspects of their business. Andain has their headquarters in Beverly Hills, California.
Andain's primary efforts are to optimize development, engineering for production, regulation, pre-clinical and clinical trials and market penetration, respectfully, to each of their products. The Company is continually working to enhance their products via new synergetic novel technologies. Their industrial incubator specializes in utilization of the industrial infrastructure of companies that they work with, optimizing each product's research and development and engineering development to the "best-in-the-market" product.
The Company's infrastructure includes two subsidiaries that support the product business units. One is a technological and industrial government-funded incubator program operated by their subsidiary - Meizam - Advanced Enterprise Center Arad Ltd. The other is a management consulting practice operated by their subsidiary Impact Active Team Ltd.
Andain has developed a novel miniature disposable insulin patch pump (Gemini). It is a technologically advanced, fully programmable, remotely controlled, robust, and low cost product. The design of it is to treat Type I and Type II diabetes for a week. The pump holds 6CC of insulin and is 49mm diameter by 7 mm thick, 25 grams in size. Smart on-line monitoring provides a real-time alert for occlusions and leakages.
In addition, with the leading researchers in Israel the Company has jointly developed a unique stem cell therapy product. By using myogenically directed stem cells, they enable treatment to ischemic limb and cardiac muscles with the use of their regenerative therapy product. Furthermore, Andain's home team successfully developed and human tested a nano-particle drug delivery system product line. It improves delivery of medications to a specific human organ. Their product lines also include an Ultrasonic catheter for brain cancer therapy and a peptide booster for anti-wrinkle cosmeceuticals.
Andain, Inc. (ANDN), closed Wednesday's trading session at $0.045, up 28.57%, on 140,000 volume with 5 trades. The average volume for the last 60 days is 8,992 and the stock's 52-week low/high is $0.035/$0.12.
DynaVox, Inc. (DVOX)
Street Insider reported earlier on DynaVox, Inc. (DVOX) and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
DynaVox, Inc. is the leading provider of speech generating devices and symbol-adapted special education software used to assist individuals in overcoming their speech, language and learning challenges. The Company's primary operating entities are DynaVox Systems LLC and Mayer-Johnson LLC. DynaVox offers their speech generating devices to speech language pathologists; they offer special education software to special education teachers and speech language pathologists. Founded in 1983, the Company is based in Pittsburgh, Pennsylvania.
DynaVox's mission is to enable their customers to realize their full communication and education potential through developing industry-leading devices, software and content and by providing the services to support them. The design of DynaVox's solutions is to assist people who have complex communication and learning needs in participating in the home, classroom and community. The Company assists individuals, families, and professionals with an extensive field support organization and centralized technical and reimbursement support.
The Company's speech generating technology solutions include DynaVox Maestro, a tablet product line of speech generating devices. Their solutions also include DynaVox Vmax+, a Series V product line designed to meet individual needs based on cognition and physical ability to operate the device. In addition, DynaVox's solutions include the EyeMax system consisting of Vmax and an EyeMax accessory, which allows users to control the Vmax with a simple blink or by causing the eye to dwell on a desired area of the screen. These are among other products that the Company offers.
DynaVox's Boardmaker line of special education software is used as a publishing and editing tool to create interactive, symbol-based educational activities and materials for special education students. Moreover, it is used to adapt text-based materials to symbol-based materials for students with limited reading skills. The Company's proprietary Picture Communication Symbols (PCS®) are used in their Boardmaker software line and their DynaVox line of speech generating devices.
DynaVox sells their speech generating devices through a direct sales force and through strategic partnerships with third-party distributors worldwide. They sell their special education software via direct mail, direct sales, and through the Web.
DynaVox, Inc. (DVOX), closed Wednesday's trading session at $0.475, down 10.38%, on 951,120 volume with 1,068 trades. The average volume for the last 60 days is 193,345 and the stock's 52-week low/high is $0.22/$3.36.
AirWare Labs Corp. (AIRW)
We are highlighting AirWare Labs Corp. (AIRW) today, here at the QualityStocks Daily Newsletter.
AirWare Labs Corp. provides patented and innovative technology solutions to consumer products promoting better health and enhanced wellbeing. The Company markets their products under the family name of AIR® by AirWare Labs. AirWare Labs studies the effects of environmental factors on breathing and the human body, and the scientifically shown benefits provided by the strategic use of therapeutic essential oils. AirWare Labs lists on the OTCBB; the Company has their headquarters in Scottsdale, Arizona.
A selective group of highly experienced doctors, engineers and scientists, who provide advice and information on research topics relevant to the Company's Mission of the Innovative Science of Breathing, supports AirWare Labs. AIR® Products start with an FDA approved medical grade silicone molded as an intranasal Air Breathe dilator. This is the AIR® delivery system. This microstructure enhances normal nasal airflow with every breath clinically proven to deliver up to 40 percent more oxygen. Certain AIR® products have an infusion of essential oils with unique healing properties. This includes antibacterial and therapeutic defense against airborne allergens, viruses and bacteria.
AIR® Allergy and Travel products have additional defense in the form of an integrated filter media from 3M to remove microscopic particles that carry viruses, allergens and bacteria. Other AIR® products specialize in helping with congestion, insomnia, headaches, nausea, snoring and performance enhancements.
Recently, AirWare Labs announced that they would expand their sales and promotional marketing efforts of the AIR® Allergy product in addition to the Sleep/Snore product as part of their continued commitment to a national rollout at Walgreens 7,500 stores. The Company has launched new marketing efforts to expand awareness for defense of the Flu. Internet search campaigns are taking place to promote AIR's® Allergy defense capabilities in context to the increased need for protection and resistance to Flu symptoms. The AIR® Allergy product has strong positioning in defense of the Flu with Eucalyptus Oil that is scientifically shown to be a natural antimicrobial that possesses disinfecting properties.
AirWare Labs Corp. (AIRW), closed Wednesday's trading session at $0.45, up 80.00%, on 1,500 volume with 2 trades. The average volume for the last 60 days is 1,749 and the stock's 52-week low/high is $0.25/$2.50.
Rainbow Coral Corp. (RBCC)
The QualityStocks Daily Newsletter would like to spotlight Rainbow Coral Corp. (RBCC). Today, Rainbow Coral Corp. closed trading at $0.36, up 3.84%, on 141,843 volume with 49 trades. The stock’s average daily volume over the past 60 days is 109,485, and its 52-week low/high is $0.27/$2.67.
Rainbow Coral Corp. reported today that the company's biotech division, Rainbow BioSciences, is currently in talks to help develop and market a revolutionary sustained-release drug delivery platform ideal for biologic agents and small molecules, improving safety, efficacy, and convenience. A joint venture with a privately held drug delivery company developing this novel technology places RBCC in prime position to dominate systemic drug delivery, including oral and IV delivery, thanks to how this technology will avoid the typical problem with systemically delivered drugs that typically can't reach sufficient concentrations in target organs to be effective without becoming dangerous to other organs.
Rainbow Coral Corp. (RBCC), via wholly owned subsidiary Rainbow Biosciences, continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. The company specifically pursues opportunities that offer short-term marketability and commercialization potential in key areas like Alzheimer's, Parkinson's, and Cancer.
Bioscience technology is a growing, dynamic field of innovation that applies life processes to practical uses, such as the manufacturing of medical devices and the development of new bioscience procedures. From pharmaceuticals to pacemakers, genetically engineered plants to gene therapy, bioscience technology can be found virtually anywhere.
The pending joint venture with Amarantus BioScience to develop and market new therapies and treatments for neurological diseases and physical traumas is a great example of the initiatives underway. In recent news, Amarantus licensed a highly promising diagnostic blood test that could become an invaluable new tool in Alzheimer's clinical trials where patient recruitment errors occur often due to inaccurate diagnosis.
The global biotech industry, currently valued at more than $84.6B, allows new players with bright ideas to quickly grab market share and create completely new markets. The exciting initiatives being driven forward by Rainbow Coral promise to transition today's leading-edge research into practical, affordable treatments for people who need them most. Disclaimer
Rainbow Coral Corp. Company Blog
Rainbow Coral Corp. News:
RBCC Opens Talks to Help Develop Revolutionary Breakthrough in $60 Billion Drug Delivery Market
RBCC Retains New IR Group to Optimize Investor Outreach, Relay Key Growth Plans
RBCC: n3D Technology Could Lead to Lab-Grown Implantable Organs
Viscount Systems, Inc. (VSYS)
The QualityStocks Daily Newsletter would like to spotlight Viscount Systems, Inc. (VSYS). Today, Viscount Systems, Inc. closed trading at $0.11, up 35.80%, on 1,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 67,739, and its 52-week low/high is $0.0069/$0.13.
Viscount Systems, Inc. (VSYS) designs, manufactures, and services access control and security products such as door access control systems and emergency communications systems. The company's products have been installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices.
Designing security systems since 1969, the company has developed strategic working relationships with leading equipment vendors to support its continued profitability and growth. Viscount has been consistently profitable for nearly 15 years and currently generates annual revenues of approximately $5 million.
Five hundred dealers help distribute Viscount's existing products throughout North America. This distribution network is not static as the company constantly pursues additional sales channels. Products are advertised in various print publications and regularly displayed at tradeshows as well. Direct marketing via training seminars also helps drive sales.
Viscount's management team has more than 60 years of combined experience in the development and production of electronic door control and telecommunication systems. Under this leadership, the SIA Convergence Solution of the Year accolade and Platinum Award for Emergency Response and Gold Award for Access Control at the Government Security Awards (GOVSEC) for 2011 have been presented to the company. Disclaimer
Viscount Systems, Inc. Company Blog
Viscount Systems, Inc. News:
Viscount Systems Awarded Contract to Secure Large Industrial Facility
Viscount Systems Awarded Contract to Secure Additional U.S. Government Facilities
Viscount Systems Receives Contract to Secure Four High Rise Towers
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.29, up 16.00%, on 28,000 volume with 5 trade. The stock’s average daily volume over the past 60 days is 12,620, and its 52-week low/high is $0.18/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Comments on Recent Balance Sheet Improvements, Channel Partners and Market Opportunities
GlobalWise CEO to Speak at Technology United Executive Conference
GlobalWise Launching Sales Campaign With Public Safety Market Leader Tiburon
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.119, up 6.16%, on 2,730,640 volume with 180 trades. The stock’s average daily volume over the past 60 days is 4,827,992, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Announces Phase 1/2 Trial of ADXS-HPV in Anal Cancer Conducted by Brown University Oncology Group
Chairman and CEO of Advaxis Featured in Exclusive SmallCapVoice Interview
Advaxis to Present at the 15th Annual BIO CEO & Investor Conference
Rainbow Coral today announced that its biotech division, Rainbow BioSciences, is currently in talks to help develop and market a revolutionary, sustained-release drug delivery platform that could soon enable safer delivery of biologic agents and small molecules, while also increasing efficacy and convenience to a whole new level.
Specifically, a joint venture agreement with a privately held drug delivery company developing the novel technology is on the table. The local delivery platform is being developed to address the issues posed by systemic drug delivery, including oral and IV delivery. Often systemically delivered drugs can’t reach sufficient concentrations in target organs to be effective without damaging the liver, kidneys, or heart. Systemic delivery also requires frequent, expensive injections in many cases.
The technology Rainbow BioSciences is currently reviewing could enable selective, site-specific delivery, allowing for lower drug concentrations and greatly reducing the risk of drug toxicity.
“Because it’s a sustained-release delivery system, patients could potentially only need one injection every six months,” said RBCC CEO Patrick Brown. “In addition to helping millions of patients struggling with chronic conditions, the technology also has the benefit of extending the patent life cycles of drugs, giving potential pharmaceutical partners a tremendous market advantage.”
“RBCC hopes to conclude its due diligence work on the drug delivery company and sign a joint venture agreement to begin getting the new technology into doctors’ hands in the next few weeks,” Brown added.
For more information on Rainbow BioSciences, visit www.rainbowbiosciences.com
Viscount Systems, Canadian-based designer and producer of commercial access control and security products for thousands of sites in over 30 countries, is introducing the world to a new-generation of commercial security.
The company is eliminating the need for the expensive and difficult to upgrade traditional approach to access control by applying advanced software and communication technologies to the process, allowing the deployment of access control on IT platforms. It’s an approach that most existing security companies have trouble with because it is fundamentally different, and they don’t have the needed IT product development and engineering skills, nor access and relationships with the “IT-side” of enterprise and government organizations.
Viscount, on the other hand, has a leadership and advisory team that is well-versed in these technologies, as well as the security industry in general.
• Steve Pineau (CEO) has been a visionary leader with Viscount since 1997 and anticipated the paradigm shift currently underway in the security industry. He thoroughly understands the operational, technological, and financial aspects of the business.
• Dennis Raefield (COO), past President of the Honeywell Access Systems division, which operates at a $100 million annual revenue level, and past President of Pinkerton Systems Integration, is an expert in the integration of large security systems.
• Shayne Bates (Advisory Team) has a long history as a thought leader in the unification of physical and logical access control, and has emphasized Active Directory in his approach, working closely with Microsoft in developing cloud strategy.
• Ron Martin (Advisory Team) is known throughout the security industry for his expertise in Identity Management and Physical Access Control systems.
• Paul Brisgone (Board Member) has 34 years of experience with ADT, most recently as the VP of their Federal Systems Division.
• Robert Liscouski (Board Member) was the first Assistant Secretary for the US Department of Homeland Security.
• Paul Goldenberg (Board Member) was appointed to the Homeland Security Advisory Council by Janet Napolitano and has a distinguished career in criminal justice.
For additional information, visit www.Viscount.com
HII Technologies is an oilfield services company serving the power, water, and safety markets with innovated solutions that are in high demand and used by exploration and production (E&P) companies. With over a decade of experience in the energy business, the company has established a solid track record as well as developed an extensive network of relationships with oil and gas E&P companies, energy consultants and advisors, vendors, suppliers, and strategic corporate partners.
HII Technologies’ power subsidiary, South Texas Power, provides portably onsite diesel and natural gas generators to E&P companies that are in remote areas and don’t have ready access to a power grid. AES Water Solutions, the company’s water transfer division, provides above ground temporary infrastructure to transfer millions of gallons of water needed in connection with hydro-fracing of oil and gas wells. HII Technologies’ safety consulting business, AES Safety Services, helps E&P companies meet the increasing state and federal requirements for 24/7 safety personnel on site from the early stages of preparing for drilling to the final completion work.
Management’s relationships in the markets it operates is a key to the company’s success. Matt Flemming, CEO of HII Technologies has twenty years’ experience as CFO and CEO of high growth companies and ten years in oil and gas services and manufacturing markets. Brent Mulliniks, P.E., is a frac engineer by training and as President of AES Water Solutions brings significant experience and knowledge to the hydro-fracing water transfer business. Jason Cuevas, GM of South Texas Power, was previously GM of National Oilwell Varco Portable Power division in the heart of the Eagle Ford Shale in S. Texas.
The company seeks differentiation of its operating divisions by accessing and acquiring technologies, as well as evaluating joint ventures, while successfully executing its organic growth strategy. Significant growth and profitability is projected by management as the company continues to meet the needs of the ever expanding energy marketplace. Leveraging an array of competitive strengths and deep expertise in the energy services business, HII Technologies is well positioned as one of the most dynamic oilfield service companies in the United States.
For more information, visit www.hiitinc.com
Using a unique funding system, Bergamo Acquisition is in the process of evaluating global investment opportunities. One strategic investment strategy involves a unique solar powered water pumping system that can be used to power the pumping and processing of water for communities in remote areas of developing nations. Not only can the system provide critical water to millions of people, it also eliminates the pollution produced by the small and inefficient combustion engines often used for pumping in third world countries.
The solar pumping system is comprised of a solar array, a power inverter, and an efficient AC pump.
• Solar Array – The array includes a number of PV modules to capture and convert sunlight to a dependable flow of DC electrical energy.
• Inverter – The proprietary electrical inverter not only converts the DC voltage from the PV modules to AC for driving the pump, it also controls and regulates the pumping operation system, monitoring the available sun energy and adjusting the output frequency to achieve maximum power.
• AC Pump – The 3-phase AC power induction water pump is submersible, and is available in a variety of sizes and types to effectively pump water from wells, rivers, or lakes.
• Processing – Bergamo can also deliver custom water treatment units in different sizes for use in the desalinization or purification of water for drinking.
The system has many additional applications, including:
• Desert Control (sea water desalinization, agricultural irrigation)
• Daily Water Supply (forest irrigation, city waterscape)
• Landscape Fountains
• Pasture Animal Husbandry
• Island Water Supply
• Wastewater Treatment
For more information, visit www.BergamoCorp.com
Today's Top 3
Investor News Source
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Chairman and CEO Featured in Exclusive SmallCapVoice Interview
- Bergamo Acquisition Corp. (BGMO) Provides Authenticated Documentation to Confirm Bank Deposits
- Consorteum Holdings, Inc. (CSRH) Reaches Funding Agreement With Private Equity Group
- Cardium Therapeutics, Inc. (CXM) Announces Presentation at The 2013 Cell & Gene Therapy Forum
- Duma Energy Corp. (DUMA) Receives 1.1 Billion Barrel P10 Estimate for Namibia Concession
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- HII Technologies, Inc. (HIIT) Announces Engagement of QualityStocks Investor Relations Services
- International Stem Cell Corp. (ISCO) Strengthens Intellectual Property Portfolio
- Loans4Less.com, Inc. (LFLS) Engages CPA Firm to Audit Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Receives General License for Pharmaceutical Products Starts Mfg. 3 New Products
- Rainbow Coral Corp. (RBCC) Opens Talks to Help Develop Revolutionary Breakthrough in $60 Billion Drug Delivery Market
- TNI BioTech Inc. (TNIB) Secures Exclusive License to Portfolio of Cancer Treatment and Prevention-Related IP
- Viaspace, Inc. (VSPC) 25 Acres of Giant King Grass Shipped and Growing in St. Croix
- Viscount Systems, Inc. (VSYS) Awarded Contract to Secure Additional U.S. Government Facilities
- VistaGen Therapeutics, Inc. (VSTA) Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium